标题
Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review
作者
关键词
-
出版物
ACTA NEUROLOGICA SCANDINAVICA
Volume 135, Issue 1, Pages 34-56
出版商
Wiley
发表日期
2016-03-19
DOI
10.1111/ane.12590
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
- (2015) Changqin Liu et al. PARKINSONISM & RELATED DISORDERS
- Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
- (2014) Min Shi et al. ACTA NEUROPATHOLOGICA
- The influence of preanalytical conditions on the DJ-1 concentration in human cerebrospinal fluid
- (2014) Lisette Salvesen et al. Biomarkers in Medicine
- Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional study
- (2014) Shu-yang Yu et al. BMC Neurology
- Premotor and nonmotor features of Parkinsonʼs disease
- (2014) Jennifer G. Goldman et al. CURRENT OPINION IN NEUROLOGY
- Oxidized DJ-1 as a possible biomarker of Parkinson’s disease
- (2014) Yoshiro Saito JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Intact Protein Analysis of Ubiquitin in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Differences in Alzheimer’s Disease and Frontotemporal Lobar Degeneration
- (2014) Patrick Oeckl et al. JOURNAL OF PROTEOME RESEARCH
- Flt3 ligand does not differentiate between Parkinsonian disorders
- (2014) Edina Silajdžić et al. MOVEMENT DISORDERS
- CSF A 42 predicts early-onset dementia in Parkinson disease
- (2014) G. Alves et al. NEUROLOGY
- Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study
- (2014) C. H. Adler et al. NEUROLOGY
- CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders
- (2014) Stefania Mondello et al. PARKINSONISM & RELATED DISORDERS
- Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
- (2013) Jing Zhang et al. ACTA NEUROPATHOLOGICA
- May the Evaluation of Nitrosative Stress Through Selective Increase of 3-Nitrotyrosine Proteins Other Than Nitroalbumin and Dominant Tyrosine-125/136 Nitrosylation of Serum α-Synuclein Serve for Diagnosis of Sporadic Parkinson's Disease?
- (2013) Emilio Fernández et al. ANTIOXIDANTS & REDOX SIGNALING
- α-Synuclein: The Long Distance Runner
- (2013) Sonia George et al. BRAIN PATHOLOGY
- Evaluation of the Cerebrospinal Fluid Amyloid-�1-42/Amyloid-�1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
- (2013) Magdalena Nutu et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity
- (2013) K. D. van Dijk et al. EUROPEAN JOURNAL OF NEUROLOGY
- Pre-analytical factors influencing the stability of cerebrospinal fluid proteins
- (2013) Anja H. Simonsen et al. JOURNAL OF NEUROSCIENCE METHODS
- 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- The glial marker YKL-40 is decreased in synucleinopathies
- (2013) Bob Olsson et al. MOVEMENT DISORDERS
- Cerebrospinal fluid biomarkers in Parkinson disease
- (2013) Lucilla Parnetti et al. Nature Reviews Neurology
- Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
- (2013) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls
- (2013) Megan K. Herbert et al. PARKINSONISM & RELATED DISORDERS
- Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
- (2013) Malin Wennström et al. PLoS One
- What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
- (2013) Christopher J.R. Dunning et al. Prion
- May Serum Levels of Advanced Oxidized Protein Products Serve as a Prognostic Marker of Disease Duration in Patients with Idiopathic Parkinson's Disease?
- (2012) José-Manuel García-Moreno et al. ANTIOXIDANTS & REDOX SIGNALING
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson’s disease and other synucleinopathies
- (2012) David S. Goldstein et al. BRAIN
- Phosphorylated α-synuclein as a potential biomarker for Parkinson’s disease and related disorders
- (2012) Penelope Foulds et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
- (2012) Valerio Pisani et al. Journal of Neuroinflammation
- Biochemical premotor biomarkers for Parkinson's disease
- (2012) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
- (2012) Chera L Maarouf et al. NEUROLOGICAL RESEARCH
- Aβ1-15/16 as a Potential Diagnostic Marker in Neurodegenerative Diseases
- (2012) Magdalena Nutu et al. NEUROMOLECULAR MEDICINE
- The DJ-1 concentration in cerebrospinal fluid does not differentiate among parkinsonian syndromes
- (2012) Lisette Salvesen et al. PARKINSONISM & RELATED DISORDERS
- Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia
- (2012) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson’s Disease Dementia
- (2012) Sarah Jesse et al. PLoS One
- Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice
- (2012) Francisco Pan-Montojo et al. Scientific Reports
- Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia
- (2011) K. Elisabet Ohlin et al. BRAIN
- CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease
- (2011) Peter LeWitt et al. BRAIN RESEARCH
- Alzheimer's disease
- (2011) Clive Ballard et al. LANCET
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- CSF α-synuclein does not differentiate between parkinsonian disorders
- (2011) M.B. Aerts et al. NEUROBIOLOGY OF AGING
- Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
- (2011) P.G. Foulds et al. NEUROBIOLOGY OF DISEASE
- Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes
- (2011) Sara Bech et al. PARKINSONISM & RELATED DISORDERS
- Neuroinflammation in Parkinson's disease
- (2011) Etienne C. Hirsch et al. PARKINSONISM & RELATED DISORDERS
- Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
- (2011) Petra Steinacker et al. PLoS One
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- CSF markers of neurodegeneration in Parkinson’s disease
- (2010) Hana Přikrylová Vranová et al. JOURNAL OF NEURAL TRANSMISSION
- CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
- (2010) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients
- (2010) Valerio Pisani et al. MOVEMENT DISORDERS
- Differential pattern of brain-specific CSF proteins tau and amyloid-beta in Parkinsonian syndromes
- (2010) Sigurd D. Süssmuth et al. MOVEMENT DISORDERS
- CSF Aβ42and tau in Parkinson's disease with cognitive impairment
- (2010) Thomas J. Montine et al. MOVEMENT DISORDERS
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Proteomic profiling of cerebrospinal fluid in parkinsonian disorders
- (2010) Radu Constantinescu et al. PARKINSONISM & RELATED DISORDERS
- Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease
- (2010) James B. Leverenz et al. PARKINSONISM & RELATED DISORDERS
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
- (2009) Dennis W Dickson et al. LANCET NEUROLOGY
- Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms
- (2009) Maria C Rodriguez-Oroz et al. LANCET NEUROLOGY
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- Transthyretin: More than meets the eye
- (2009) Carolina Estima Fleming et al. PROGRESS IN NEUROBIOLOGY
- CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
- (2008) Jing Zhang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
- (2008) Lucilla Parnetti et al. BIOLOGICAL PSYCHIATRY
- BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease
- (2008) T Foltynie et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
- Free Copper, Ferroxidase and SOD1 Activities, Lipid Peroxidation and NO x Content in the CSF. A Different Marker Profile in Four Neurodegenerative Diseases
- (2008) Marie-Catherine Boll et al. NEUROCHEMICAL RESEARCH
- Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers
- (2008) Alexander I. Tröster NEUROPSYCHOLOGY REVIEW
- Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy
- (2008) David S. Goldstein et al. PARKINSONISM & RELATED DISORDERS
- Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease
- (2008) Gianluigi Lunardi et al. PARKINSONISM & RELATED DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now